ã¡ãã£ã¢èšäº
米ãã³ããã¯ã¯ãã³æ¥çš®ã幎1åããææ¡
ããºãææ°ããŒã¯ 110
twitterã³ã¡ã³ã 83ä»¶äž 1ïœ83件
ãã€ã®éã«ã幎äžåïŒ
ãã€ãŸã§ãxåç®æ¥çš®ãããããã§ãããããæ¥çš®ããšã«å¹æãèããïŒãããããªãïŒãšãèãã®ã§ãããã6ãæãããã§å®æçã«æ¥çš®ãããã®ã§ããã
ã¢ã¡ãªã«ã§ãããŸã å®ææ¥çš®ãâææ¡âãšãèšã£ãŠããããã§ããã
ã¢ã¡ãªã«ã§ãããŸã å®ææ¥çš®ãâææ¡âãšãèšã£ãŠããããã§ããã
ã€ã³ãã«ãšã³ã¶ã¿ããã«åŠæ ¡ã§äºé²æ¥çš®ãšã¯å§ãŸãã®ã§ã¯
誰ãæã€ããã±ãŒïŒ
ïŒã¶æã§å¹æãåãããšãèšããŠããã¡ãããïŒ
ã»ããŸèš³åãããäºã°ã£ããããªã
ã»ããŸèš³åãããäºã°ã£ããããªã
ç·æ¥äœ¿çšèš±å¯ãç¹äŸæ¿èªã®ãŸãŸãšãããããã£å§ããŠãæ£åŒãªèªå¯ã¯æ¥çš®è
ã®æ§åãæ°å¹Žåäœã§ããŒã¿éç©ããŠããã£ãŠäºã«ãªãã®ããªã
æ¥æ¬ãè¿œéããããã ãã€ã³ãã«ãšåãããã«ãæã¡ãã人ãæãŠã°ãããäžéšå ¬çè² æ ã¯ãªãã§ãããã
æ¥æ¬ãè¿œéããããã ãã€ã³ãã«ãšåãããã«ãæã¡ãã人ãæãŠã°ãããäžéšå ¬çè² æ ã¯ãªãã§ãããã
å¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ãããäžéšã®åã©ããé«éœ¢è
ã®ä»ãå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
"äžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã"
å€åããããžããèœãšãæãã
å€åããããžããèœãšãæãã
ããã«ã¹ã¿ã³ããŒãã
ããã¢ãªè§£éããã°è©°ã
ä¿¡çšãªã©åŸ®å¡µãããããããªãã
ä»è¿è¿°ã¹ãŠããããšå šéšäžŠã¹ãŠã¿ãã°ãããããã
ããã¢ãªè§£éããã°è©°ã
ä¿¡çšãªã©åŸ®å¡µãããããããªãã
ä»è¿è¿°ã¹ãŠããããšå šéšäžŠã¹ãŠã¿ãã°ãããããã
çŽ æŽãããïŒ
åºæ¥ãã°ãã€ã³ãã«ãšã³ã¶ãšæ··åã®ã¯ã¯ãã³ã«ããŠã»ããã
åã¯ãã¡ããææã§ãééããªãæã€ïŒ
åºæ¥ãã°ãã€ã³ãã«ãšã³ã¶ãšæ··åã®ã¯ã¯ãã³ã«ããŠã»ããã
åã¯ãã¡ããææã§ãééããªãæã€ïŒ
ðµãŸã èšã£ãŠããã
2025æ°ããªâŠïœ±ïŸïŸèº«ãåããã®ãïŸïœ°ïŸð
ãŠããšã«ãªããªãããã«
ä»ããè±çš®ããŠå¥åº·ãåãæ»ãð€
ä»å¹Žãã2024ã¯å éç
ããæããããŠã¯ãããŸããã
ã¢ã¬ãã³ã¬ãåãè¿ãæã§ãðððª
ã
2025æ°ããªâŠïœ±ïŸïŸèº«ãåããã®ãïŸïœ°ïŸð
ãŠããšã«ãªããªãããã«
ä»ããè±çš®ããŠå¥åº·ãåãæ»ãð€
ä»å¹Žãã2024ã¯å éç
ããæããããŠã¯ãããŸããã
ã¢ã¬ãã³ã¬ãåãè¿ãæã§ãðððª
ã
ã€ãŸãæ¥æ¬äººã«å¯ŸããŠã ããw
ã³ããð§ ã®äººã¯ãã£ãšæã£ãŠãð€£
ã³ããð§ ã®äººã¯ãã£ãšæã£ãŠãð€£
æ¥æ¬ãç¶ããŠãããã ããªâºïž
çã£å¹³ãããã§ãð¡ð¡ð¢
å
ç«åäœäžããŠã人ã¯å¹Ž2å
æå³ãããããã
(ã»ã»?)(ã»ã»?)
æå³ãããããã
(ã»ã»?)(ã»ã»?)
FDAã¯23æ¥ãã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«äºé²æ¥çš®ãšåæ§ã«1幎ã«1åãšããããšãææ¡ã
äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«2åã®æ¥çš®ãæ€èšããããæ±ããã
äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«2åã®æ¥çš®ãæ€èšããããæ±ããã
幎äžåããããªãâŠïŒ
âŠ
âŠ
ãŸãèšå®ãã©ããè¡ã£ãŠããŸããŸãããwïŒã¶æã§å
ç«åãäžããããããªãã£ãã®ïŒå¹Ž1åïŒw
å·åä¿åããªããšäœ¿ããªããšããèšå®å€ãããããããªãã§ããïŒ
ããããããããæã«ãã¡ã¯ããã§ãã¯ããªãã®ã¯äœæ ïŒ
å·åä¿åããªããšäœ¿ããªããšããèšå®å€ãããããããªãã§ããïŒ
ããããããããæã«ãã¡ã¯ããã§ãã¯ããªãã®ã¯äœæ ïŒ
ãå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯å¹Žã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãããã£ãŠèšã£ãŠãã»ã»ã»
æ¥æ¬ã®å¥Žé·ã©ãã¯3ã¶æããšã«æãããããã§ããã
幎ïŒåã«ããçã
ãïŒæ¬¡æ¥çš®ãåããŠããªãæªæ¥çš®è ããææ°ã®ã¯ã¯ãã³ãåžžã«æãŠãããã«ãªããïŒç±³å ±éïŒã
WHOã®æ³æ¹æ£ãæµ·å€ã¯ã¯ãã¹ãæ§ããæŠç¥ãåãæ¿ããŠæ¥ãŸããïŒïŒ
æ°ãã€ããŸãããïŒ
ãïŒæ¬¡æ¥çš®ãåããŠããªãæªæ¥çš®è ããææ°ã®ã¯ã¯ãã³ãåžžã«æãŠãããã«ãªããïŒç±³å ±éïŒã
WHOã®æ³æ¹æ£ãæµ·å€ã¯ã¯ãã¹ãæ§ããæŠç¥ãåãæ¿ããŠæ¥ãŸããïŒïŒ
æ°ãã€ããŸãããïŒ
ãŸãããã®ããããè¿ããã¡ã«ãçŸå®çãªèœãšãã©ãããã«ãªããã ãããªã
â·
â·
ãšã¯æè©®ããããçµç¹
æ»ã¬ãŸã§æãããã€ããã§ãã
éšãããŠã¯ãããŸãããã
æ»ã¬ãŸã§æãããã€ããã§ãã
éšãããŠã¯ãããŸãããã
Q. ããããå
ã® ã®è¿œå æ¥çš®ã¯ã©ããªãããïŒ
å æ°ãªå€§äºº 幎1å
æäœäœãåã匱ã
é«éœ¢è ãäžéšã®ãåãã 幎2å
確å®ã§ã¯ãªããã©ã
FDAããèŠè§£ãåºãã¯ã³ð¶
yahoo
newyork times
å æ°ãªå€§äºº 幎1å
æäœäœãåã匱ã
é«éœ¢è ãäžéšã®ãåãã 幎2å
確å®ã§ã¯ãªããã©ã
FDAããèŠè§£ãåºãã¯ã³ð¶
yahoo
newyork times
æã£ãŠããããããæã£ãŠäœèª¿æªããªããããªãã®ã¯å¿
èŠãããŸããããã
ã³ãã³ãå€ãããªãããããªããäžçæãããã©ã
ç±³é£åå»è¬åå±ïŒŠïŒ€ïŒ¡ã¯ïŒïŒæ¥
æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®
ïŒïŒæ¥ã«éãããå€éšå°é家ã®äŒåã«å ç«ã¡ã説æææžãäœæ
ðŽæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®åæ§
ïŒå¹Žã«ïŒåãšææ¡
ðŽäžéšã®åã©ããé«éœ¢è
å ç«åãäœäžããŠãã人ã«å¹Žã«ïŒåã®æ¥çš®ãæ€èš
æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®
ïŒïŒæ¥ã«éãããå€éšå°é家ã®äŒåã«å ç«ã¡ã説æææžãäœæ
ðŽæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®åæ§
ïŒå¹Žã«ïŒåãšææ¡
ðŽäžéšã®åã©ããé«éœ¢è
å ç«åãäœäžããŠãã人ã«å¹Žã«ïŒåã®æ¥çš®ãæ€èš
ãç±³é£åå»è¬åå±âŠã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ããããäžéšã®åã©ããé«éœ¢è
âŠå¹Žã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãããâã ããã
ïŒå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ããã
ïŒäžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
ïŒäžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
åœããåã ãããäžå¹Žéã«äœåºŠãæ¥çš®ãããªããŠãããããïŒäººéã®äœã§æ®é£¯åŠçã¿ããã«ãããããå¹æã®ãªãæ¯ãã³ã ãããšèšã£ãŠãé
·ãããªãïŒãããæ¥æ¬äººäžå€«ã§ãæããªãããã ããè¶
éæ»äº¡çã«ãªã£ãŠãã§ããã
幎ã«äžåãšèšãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³ã®ãããªã¡ãªããããããªããã£ãšæ©ãæããã¹ãã ã£ãã3,4åæ¥çš®ããŠããç¡é§ã«æ¥çš®ããŠã
ãã®èšè
äŒèŠããªãããã¯ããæ¹ããã·ã ãšæããã©ã»ã»ã» CDC æ±äº¬æ¯å±ãã§ããããšã ã æ¥æ¬ã¯ã¢ã¡ãªã«ã®åœä»€ã«ä»åŸåŸããããããâ¬ïž
ç±³FDAãã幎1åãã®ã³ããæ¥çš®ãææ¡ã
ç±³FDAãã幎1åãã®ã³ããæ¥çš®ãææ¡ã
äœããªãã§ãæãããããããã
米ãã³ãã ã¯ã¯ãã³æ¥çš®ã幎1åããææ¡ âŠ
ã»ããåºãŠããã
æåãããããªãäºã¯ããã£ãŠãã
æ¯å¹Žæããªããã°ãªããªãð
å»çäŸåãå¢ããã
ããããããã
ç®æãæ¹åã¯ãè±äŸåãã ãã
æåãããããªãäºã¯ããã£ãŠãã
æ¯å¹Žæããªããã°ãªããªãð
å»çäŸåãå¢ããã
ããããããã
ç®æãæ¹åã¯ãè±äŸåãã ãã
ã®å»æ¢ã§ã¯ãªããŠ
ã«ãããšããããšã¯âŠ
ããããããšã«ãªãïŒ
ã«ãããšããããšã¯âŠ
ããããããšã«ãªãïŒ
ããã¯ããã西æŽå»åŠãä¿¡çšãããªâŒïžã£ãŠäºãèšã£ãŠããšããæããªãã
æ¥æ¬ã¯ã©ããªã
æ®ã©ãããããã
æ¡ã®å®
2åã§çµçå ç«ã7å²ã§æ¥åžžãæ»ããã ã£ãããºããããããããšå®ææ¥çš®ããããå幎æ¯(3ãµææ¯ãããªãã®ã¯è¯å¿?)
ã¯ã¯ãã³ç€Œè³å±€ãšããç€ç³ãªé¡§å®¢ã確ä¿æžããããã¬ã³ã倧æåãäžçªã®é¡§å®¢ã¯æ¥æ¬äººãã
2åã§çµçå ç«ã7å²ã§æ¥åžžãæ»ããã ã£ãããºããããããããšå®ææ¥çš®ããããå幎æ¯(3ãµææ¯ãããªãã®ã¯è¯å¿?)
ã¯ã¯ãã³ç€Œè³å±€ãšããç€ç³ãªé¡§å®¢ã確ä¿æžããããã¬ã³ã倧æåãäžçªã®é¡§å®¢ã¯æ¥æ¬äººãã
--幎äžåæãŠãšã匷å¶ã«ããã ãããª
幎äžåã®æ ¹æ ã¯ïŒå¹Žäžåæã€ã¯ã¯ãã³ãããªãã£ãã®ãïŒ
幎äžåã®æ ¹æ ã¯ïŒå¹Žäžåæã€ã¯ã¯ãã³ãããªãã£ãã®ãïŒ
å¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãäžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãã
âæ¯å¹Žã®ã€ã³ãã«ã¯ã¯ãã³ããã«ããã¯ã¯ãã³ã«å€ãã
âæ¯å¹Žã®ã€ã³ãã«ã¯ã¯ãã³ããã«ããã¯ã¯ãã³ã«å€ãã
1åããâïž
" äžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåâŠ"ïŒ
â²æ¬åœã®ã¢ã¡ãªã«ã¯ãããå°ã£ãŠãªãã
ããã«å¯Ÿããããã³ã®ãå°é家ãã¯å¯ã è«Ÿã ãš ?
â²æ¬åœã®ã¢ã¡ãªã«ã¯ãããå°ã£ãŠãªãã
ããã«å¯Ÿããããã³ã®ãå°é家ãã¯å¯ã è«Ÿã ãš ?
ãã®æ¹éã¯è³æããã ãã®å Žåãé·æçãªã¡ãªããã»ãã¡ãªãããæããã«ããäžã§ãå®å
šã«å®å
šãªã¯ã¯ãã³ãšããŠæ£èŠæ¿èªãå¿
é ãããŸæ¥æ¬ã§äœ¿çšãããŠããç¹äŸæ¿èªãããã¯ã¯ãã³ããã®ãŸãŸå®ææ¥çš®ã«äœ¿çšããããšã¯èš±ãããŸãã
æè¬ãèœãšãæããªã®ããªã
ã·ãŒãºã³æ¯ã«æã€ã®ã¯é£ãããããã
ã§ããã°ã€ã³ãã«ãšã³ã¶ãšæ··å補å€äœã£ãŠãç泚ãã§é ŒãâŠã
ã·ãŒãºã³æ¯ã«æã€ã®ã¯é£ãããããã
ã§ããã°ã€ã³ãã«ãšã³ã¶ãšæ··å補å€äœã£ãŠãç泚ãã§é ŒãâŠã
幎1åå ±éãã
ãããè©å€ã¯ããªãèœã¡ãŠããŸã£ã
ã©ããããã ããïŒ
ãããè©å€ã¯ããªãèœã¡ãŠããŸã£ã
ã©ããããã ããïŒ
ãŸããçœ ã«ããã人ããããã§ããããã
å»ã¯ã©ã¯åªåã足ããªãããããªãã~ïŒ
FDAã®è °ãåŒããŠãããã
ã€ã¹ãã¹èšããã«3ã¶æããšæãŠïŒ
ã ãïŒ
FDAã®è °ãåŒããŠãããã
ã€ã¹ãã¹èšããã«3ã¶æããšæãŠïŒ
ã ãïŒ
ã€ããã®éãŸã§3ã¶æã«1åæ¥çš®ã ã£ãã®ã«ãªãã§ã ãããªã
ç±³ã®ææ¡æªã«ããèŠããªããªã£ãŠãããæ¥æ¬ã®å
åäœã®è¡çšãæãç°¡åã«æšªæµããããŠæ害äºè±¡ããŸãšãã«èª¿ã¹ãªããç±³ã®æ€æ°å°ãïŒ
"å¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ããã
äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãã"
äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãã"
æãïŒ
æªæ¥çš®è
ã
æãŠãããã«ããðââïž
.
幎ïŒåã«ããçããïŒæ¬¡æ¥çš®ãåããŠããªãæªæ¥çš®è ããææ°ã®ã¯ã¯ãã³ãåžžã«æãŠãããã«ãªããïŒç±³å ±éïŒãWHOã®æ³æ¹æ£ãæµ·å€ã¯ã¯ãã¹ãæ§ããæŠç¥ãåãæ¿ããŠæ¥ãŸãããæ°ãã€ããŸãããã
æãŠãããã«ããðââïž
.
幎ïŒåã«ããçããïŒæ¬¡æ¥çš®ãåããŠããªãæªæ¥çš®è ããææ°ã®ã¯ã¯ãã³ãåžžã«æãŠãããã«ãªããïŒç±³å ±éïŒãWHOã®æ³æ¹æ£ãæµ·å€ã¯ã¯ãã¹ãæ§ããæŠç¥ãåãæ¿ããŠæ¥ãŸãããæ°ãã€ããŸãããã
ã幎1å ã³ããã¯ã¯ãã³ã
ãŸã èšåºçãªããŒã¿ãç¡ãã§ããâ¥éçåäºé²ã®ããã«ã¯åŠ¥åœãªæ°ãããŸãã
ãç±³FDAã¯ã³ããã¯ã¯ãã³æ¥çš®ã«ã€ããŠå¥åº·ãªæ人ã¯å¹Ž1åãšããããšãææ¡ãäžéšã®åã©ããé«éœ¢è ãå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯å¹Ž2åæ¥çš®ãæ€èšã
ãŸã èšåºçãªããŒã¿ãç¡ãã§ããâ¥éçåäºé²ã®ããã«ã¯åŠ¥åœãªæ°ãããŸãã
ãç±³FDAã¯ã³ããã¯ã¯ãã³æ¥çš®ã«ã€ããŠå¥åº·ãªæ人ã¯å¹Ž1åãšããããšãææ¡ãäžéšã®åã©ããé«éœ¢è ãå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯å¹Ž2åæ¥çš®ãæ€èšã
ææ¡ãåŽäžããŸãã
æ¥æ¬ããããªãããã§ããð€
FDAã¯ãæ°åã³ããã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«1幎ã«1åãšããããšãææ¡ããã
ãŸãäžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«ãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«2åã®æ¥çš®ãæ€èšããããæ±ããã
FDAã¯ãæ°åã³ããã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«1幎ã«1åãšããããšãææ¡ããã
ãŸãäžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«ãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«2åã®æ¥çš®ãæ€èšããããæ±ããã
ãžã§ããµã€ãç¶è¡äŒç»
ãããã£ãŠãæã€ã®ãåœããåã®ããã«æèèªå°ããŠãããã©ãéžæã¯èªç±ãããããã
äœãæ ¹æ ã«ææ¡ããŠãããããæ°åã³ãð±ã«ã¯ååšèšŒæããç¡ãã®ã«ã
ã¯ã·ã¯éžæè¢ãªããæããã®äžæãã€ã³ãã«ã¯ã¯ã«ããŠããæ¥çš®ãæªæ¥çš®ã§çœ¹æ£çã¯åããããã
äœãæ ¹æ ã«ææ¡ããŠãããããæ°åã³ãð±ã«ã¯ååšèšŒæããç¡ãã®ã«ã
ã¯ã·ã¯éžæè¢ãªããæããã®äžæãã€ã³ãã«ã¯ã¯ã«ããŠããæ¥çš®ãæªæ¥çš®ã§çœ¹æ£çã¯åããããã
ã¯ã¯ãã³ãšãã©ãã§ããããã
ã³ããã®çºçåå ãå¥åº·æ³ãäŒããŠã»ããã
ã³ããã®çºçåå ãå¥åº·æ³ãäŒããŠã»ããã
ãèšäºïŒ2023/01/24 - 12:53 åå Reuters_co_jp Websiteã
ç±³é£åå»è¬åå±ïŒïŒŠïŒ€ïŒ¡ïŒã¯ïŒïŒæ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ãã
ããã³ããã¯ã¯ãã³ã«é Œããã§ãŒãºã¯çµãããªã®ãããããŸãã
米æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ãã
米æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ãã
äžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èš
â
ïœïŒ²ïŒ®ïŒ¡ã¯ã¯ãã³ãæã¡ç¶ãããšãå ç«åãäœæžããŠããã®ã§ã
éå£å ç«ãªããŠãåŠæ³ã§ã
æž©æåè³ãšåã
â
ïœïŒ²ïŒ®ïŒ¡ã¯ã¯ãã³ãæã¡ç¶ãããšãå ç«åãäœæžããŠããã®ã§ã
éå£å ç«ãªããŠãåŠæ³ã§ã
æž©æåè³ãšåã
å
ç倧å€ã§ãðµ
ã¢ã¡ãªã«ã§ã¯ã¯ã¯ãã³æ¥çš®ã1幎ã«1åã«ãªãããã§ãðâïžð
TVãããããã¥ãŒã¹ã§ã¯ã¯ãã³ãå§ããŠãã埡çšå°é家ãå©æš©å»åž«ãã¡ã®çœªã¯éãðš
ã¢ã¡ãªã«ã§ã¯ã¯ã¯ãã³æ¥çš®ã1幎ã«1åã«ãªãããã§ãðâïžð
TVãããããã¥ãŒã¹ã§ã¯ã¯ãã³ãå§ããŠãã埡çšå°é家ãå©æš©å»åž«ãã¡ã®çœªã¯éãðš
èšäºã®éãç±³åœã¯ã€ã³ãã«ãšã³ã¶ãšåçã®èãã«èµåãããã®ã§ããã°ãå¬ã«ãã¹ã¯ããã®ãçã«ããªãçã§ããã
å±éºãªã¯ã¯ãã³ã¯ããèŠããŸãã
ã€ã³ãã¿ããã«ã¯ã£ããNOãšæãããšã ãã
âŠ
ã€ã³ãã¿ããã«ã¯ã£ããNOãšæãããšã ãã
âŠ
æ°žé å€ç° æ°žé ã«VAX æ°žé ã«å²ããã»ã»ã»ã
ç³ã®äžã§ã¯æ»ãããã©ã£
ç³ã®äžã§ã¯æ»ãããã©ã£
çµå±ããªãã®æ ¹æ ããªãã£ããšããããš
â
â
ãã¯ïŒïŒæ¥ã«éãããå€éšå°é家ã®äŒåã«å
ç«ã¡ã説æææžãäœæãäžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
幎1åãå
ç«ãäœäžããŠããè
ã«ã¯å¹Ž2åã ããã ãããã¯æå ±ãšãèšãããFDAã®èšãéãã«ããã°ã©ãã©ã害ãæ確ã«ãªããä»ããæã€äººéã«åæ
ããè
ãããªãã ããã奜ãã«ããã°ãã
å
ç«ã®åé¡ããã人ã¯å¹Žã«2åã£ãŠäœãåºæºã«èšã£ãŠãã®ããåšåº«åŠåã«äººã®å€§åãªåœã䜿ããªãã§ã
ãã£ã±ãããããªãããª
æ¥æ¬ãå®ææ¥çš®ã£ãŠä»¥åããèšã£ãŠããâŠè¿œéããã ããã
æ¥æ¬ãå®ææ¥çš®ã£ãŠä»¥åããèšã£ãŠããâŠè¿œéããã ããã
ðºðž ðºðžð ðæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãâïžå¥åº·ãªæ人ã«å¯ŸããŠã¯âïžã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ããã
>ç±³é£åå»è¬åå±ïŒïŒŠïŒ€ïŒ¡ïŒã¯ïŒïŒæ¥ãæ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã«ã€ããŠãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡
>äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãã
>äžéšã®åã©ããé«éœ¢è ã®ã»ããå ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãã
æ²ããªã奎ãã ã
ãŸããç±³åœæ°ã¯æããªãã ãããã©ãã
ãŸããç±³åœæ°ã¯æããªãã ãããã©ãã
ãäžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
å ç«ãäœäžãããŒæããŒã¯ã¯ãã³æãŠãŒ
ã£ãŠãã¯ã¯ãã³ã®ããã§å ç«äœäžããŠãã®ã«ãïŒ
ããžã§æ®ºãã«ããã£ãŠããªã
å ç«ãäœäžãããŒæããŒã¯ã¯ãã³æãŠãŒ
ã£ãŠãã¯ã¯ãã³ã®ããã§å ç«äœäžããŠãã®ã«ãïŒ
ããžã§æ®ºãã«ããã£ãŠããªã
ã¯ïŒïŒæ¥ã«éãããå€éšå°é家ã®äŒåã«å
ç«ã¡ã説æææžãäœæãäžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ããã
ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«
ïŒå¹Žã«ïŒåãå®çããã®ããªð
米ãã³ããã¯ã¯ãã³æ¥çš®
ã幎1åããææ¡
ïŒå¹Žã«ïŒåãå®çããã®ããªð
米ãã³ããã¯ã¯ãã³æ¥çš®
ã幎1åããææ¡
FDAãå¥åº·ãªæ人ã«å¯ŸããŠã¯ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ãšåæ§ã«ïŒå¹Žã«ïŒåãšããããšãææ¡ãäžéšã®åã©ããé«éœ¢è
ã®ã»ããå
ç«åãäœäžããŠãã人ã«å¯ŸããŠã¯ã幎ã«ïŒåã®æ¥çš®ãæ€èšããããæ±ãããã
5é¡ã ãšæ¥æ¬ãð¢
5é¡ã ãšæ¥æ¬ãð¢
ã¡ãã£ãšäœèšã£ãŠãããããããªãã
ããã ãäžçã§éšãããŠãã®ã«ããŸã ããããšããŠãã®?
ãããå ç«äœäžã®äººã«ã¯2åã ã£ãŠ?
ãµããããªã£ãŠð
ã¯ã¯ãã³ã®ããã§å ç«äœäžãæ»ã«ããããã
6æããã€ã³ãã«ãšã³ããæ··åðã«ãªãããâ
ãããå ç«äœäžã®äººã«ã¯2åã ã£ãŠ?
ãµããããªã£ãŠð
ã¯ã¯ãã³ã®ããã§å ç«äœäžãæ»ã«ããããã
6æããã€ã³ãã«ãšã³ããæ··åðã«ãªãããâ
ãããªç©ºããŠãããã§ããïŒïŒ
ïŒã¯ã¯ãã³å ç«èœã¡ãŸãããïŒ
è²ã æ®å¿µã§ããã